|Articles|October 1, 2015
Inclusion/Exclusion Criteria Show Minimal Rise
Author(s)Harold E. Glass, PhD
A review of public data indicates a small increase in Phase III inclusion/exclusion criteria per trial over a five-year period.
Advertisement
Few topics occasion the lamentations of clinical trial professionals more than the topic of patient inclusion/exclusion criteria in clinical protocols. ClinicalTrials.gov represents an important public data source to establish baseline numbers of inclusion/exclusion criteria. A review of these publicly available data shows that there is a small increase in the number of commercially funded Phase III inclusion/exclusion criteria per trial, but nowhere as dramatic as is sometimes portrayed in industry press and industry conferences.
Every year, there is a statistically significant 0.41 increase in inclusion/exclusion criteria totals in commercially funded Phase III studies. Although the increase is not large, the mere size of the database itself helps to make even mild changes seem statistically significant. Two MedDRA therapeutic areas, renal and urinary disorders as well as gastrointestinal disorders, differ statistically significantly from the overall trend, evidencing slight declines in the total number of criteria.
Articles in this issue
almost 10 years ago
Top Investigator Lays out Strategy for Avoiding Conflictsalmost 10 years ago
Changes Ahead for Informed Consent, IRBs, Transparencyalmost 10 years ago
Europe: At Last, the Hunt is On for Trials That Fit Sciencealmost 10 years ago
Developing New Alzheimer’s Drugs With a Focus on Patient Safetyalmost 10 years ago
Inclusion/Exclusion Criteria Show Minimal Risealmost 10 years ago
A New Look at the Arsenal of Tech Solutionsalmost 10 years ago
Human Gene Transfer Studies: What Clinicians Should Knowalmost 10 years ago
Death Waivers an Incomplete Picture of Drug Safetyalmost 10 years ago
Evaluating the Effects of Therapy Maskingalmost 10 years ago
Satisfaction of Healthy Subjects in Phase I Trialsalmost 10 years ago
Applied Clinical Trials Digital Edition - October/November 2015Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Using AI Trial-Matching Tools to Accelerate Patient Access
September 8th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Using AI Trial-Matching Tools to Accelerate Patient Access
2
Pfizer, BioNTech’s Comirnaty Shows Strong Immune Response in Phase III Trial for COVID-19
3
Beyond the Algorithm: How Human-Centered AI Design Can Drive Clinical Trial Success
4
ACT Brief Episode 7: Veeva and Merck Trial Efficiency, DCT Barriers, and Glucose Monitoring Strategies
5